Thrivent Financial for Lutherans’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.6M Buy
564,839
+19,264
+4% +$2.07M 0.13% 188
2025
Q1
$54.5M Sell
545,575
-3,789
-0.7% -$378K 0.12% 224
2024
Q4
$49M Buy
549,364
+182,557
+50% +$16.3M 0.1% 279
2024
Q3
$30.7M Buy
366,807
+32,844
+10% +$2.75M 0.06% 361
2024
Q2
$25.7M Buy
333,963
+139,392
+72% +$10.7M 0.05% 387
2024
Q1
$13.3M Sell
194,571
-6,126
-3% -$420K 0.03% 577
2023
Q4
$11.6M Sell
200,697
-1,582
-0.8% -$91.5K 0.03% 588
2023
Q3
$10.7M Buy
202,279
+23,424
+13% +$1.24M 0.03% 582
2023
Q2
$9.67M Buy
178,855
+111,391
+165% +$6.02M 0.02% 656
2023
Q1
$3.37M Buy
67,464
+244
+0.4% +$12.2K 0.01% 977
2022
Q4
$3.11M Buy
67,220
+5,079
+8% +$235K 0.01% 990
2022
Q3
$2.41M Sell
62,141
-5,955
-9% -$231K 0.01% 1110
2022
Q2
$2.54M Sell
68,096
-5,965
-8% -$222K 0.01% 1099
2022
Q1
$3.28M Sell
74,061
-3,798
-5% -$168K 0.01% 1045
2021
Q4
$3.31M Buy
77,859
+1,158
+2% +$49.2K 0.01% 1085
2021
Q3
$3.33M Buy
76,701
+15,674
+26% +$680K 0.01% 1065
2021
Q2
$2.61M Buy
61,027
+268
+0.4% +$11.5K 0.01% 1246
2021
Q1
$2.35M Sell
60,759
-1,417
-2% -$54.8K 0.01% 1320
2020
Q4
$2.24M Sell
62,176
-2,170
-3% -$78K 0.01% 1247
2020
Q3
$2.46M Sell
64,346
-1,170
-2% -$44.7K 0.01% 1049
2020
Q2
$2.3M Buy
65,516
+1,987
+3% +$69.8K 0.01% 988
2020
Q1
$2.07M Hold
63,529
0.01% 936
2019
Q4
$2.87M Buy
63,529
+265
+0.4% +$12K 0.01% 872
2019
Q3
$2.57M Buy
63,264
+302
+0.5% +$12.3K 0.01% 874
2019
Q2
$2.71M Buy
62,962
+1,153
+2% +$49.6K 0.01% 858
2019
Q1
$2.37M Sell
61,809
-25,072
-29% -$962K 0.01% 877
2018
Q4
$3.07M Buy
86,881
+1,064
+1% +$37.6K 0.01% 725
2018
Q3
$3.3M Sell
85,817
-130,239
-60% -$5.01M 0.01% 742
2018
Q2
$7.07M Buy
216,056
+630
+0.3% +$20.6K 0.02% 579
2018
Q1
$5.89M Buy
215,426
+159,749
+287% +$4.36M 0.02% 613
2017
Q4
$1.38M Buy
55,677
+1,011
+2% +$25.1K ﹤0.01% 1086
2017
Q3
$1.59M Buy
54,666
+3,196
+6% +$93.2K 0.01% 948
2017
Q2
$1.43M Buy
51,470
+1,430
+3% +$39.6K 0.01% 951
2017
Q1
$1.24M Buy
50,040
+2,590
+5% +$64.4K 0.01% 1053
2016
Q4
$1.03M Sell
47,450
-61,130
-56% -$1.32M ﹤0.01% 1137
2016
Q3
$2.58M Buy
108,580
+970
+0.9% +$23.1K 0.01% 788
2016
Q2
$2.52M Buy
107,610
+1,750
+2% +$40.9K 0.01% 797
2016
Q1
$1.99M Buy
105,860
+68,020
+180% +$1.28M 0.01% 863
2015
Q4
$698K Buy
37,840
+1,190
+3% +$22K ﹤0.01% 1204
2015
Q3
$601K Buy
36,650
+2,000
+6% +$32.8K ﹤0.01% 1133
2015
Q2
$613K Sell
34,650
-1,503,880
-98% -$26.6M ﹤0.01% 1009
2015
Q1
$27.3M Buy
1,538,530
+151,480
+11% +$2.69M 0.15% 163
2014
Q4
$18.4M Sell
1,387,050
-84,750
-6% -$1.12M 0.1% 226
2014
Q3
$17.4M Buy
1,471,800
+32,200
+2% +$380K 0.1% 218
2014
Q2
$18.4M Buy
1,439,600
+1,408,550
+4,536% +$18M 0.1% 208
2014
Q1
$420K Sell
31,050
-200
-0.6% -$2.71K ﹤0.01% 1047
2013
Q4
$376K Hold
31,250
﹤0.01% 1125
2013
Q3
$367K Sell
31,250
-15,350
-33% -$180K ﹤0.01% 1088
2013
Q2
$432 Buy
+46,600
New +$432 ﹤0.01% 999